Breaking News
Get 50% Off 0
Close

Danaher Corporation (DHR)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Danaher's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
243.54 -1.25    -0.51%
19/07 - Closed. Currency in USD ( Disclaimer )
After Hours
246.91
+3.35
+1.38%
0:38:47 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 2,982,627
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 241.00 - 245.25
Danaher 243.54 -1.25 -0.51%

Danaher Corporation Company Profile

 
Get an in-depth profile of Danaher Corporation, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryHealthcare Equipment & Supplies
SectorHealthcare
Employees

62000

Equity Type

ORD

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; microscopes; protein consumables; industrial filtration products; and genomic medicines, such as custom nucleic acid products, plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX and SCIEX brands. The Diagnostics segment offers chemistry, immunoassay, microbiology, and automation systems; and molecular, acute care, and pathology diagnostics products. This segment also provides clinical instruments, reagents, consumables, software, and services for hospitals, physicians’ offices, reference laboratories, and other critical care settings. The company has a research collaboration with Stanford University's Department of Bioengineering for cancer drug development. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is based in Washington, the District of Columbia.

Contact Information

Address 2200 Pennsylvania Avenue, North West Suite 800 West
Washington, 20037-1701
United States
Phone 202 828 0850
Fax 202 828 0860

Top Executives

Name Age Since Title
Mitchell P. Rales 66 1983 Co-Founder & Director
Rainer M. Blair 59 2014 President, CEO & Director
Alan G. Spoon 72 1999 Independent Director
Steven M. Rales 72 1983 Co-Founder & Chairman
Linda Hefner Filler 63 2005 Lead Independent Director
John T. Schwieters 83 2003 Independent Director
Raymond C. Stevens 60 2017 Independent Director
Teri L. List-Stoll 61 2011 Independent Director
Elias Adam Zerhouni 73 2009 Independent Director
Pardis C. Sabeti 48 2019 Director
Carl H. June 70 2022 Member of the Scientific Advisory Board
Jessica L. Mega 49 2019 Independent Director
James J. Collins 58 2021 Member of Scientific Advisory Board
A. Shane Sanders 61 2021 Independent Director
David R. Walt 71 2021 Member of Scientific Advisory Board
Angela M. Caliendo - 2021 Member of Scientific Advisory Board
Thomas Christian Sudhof 69 2021 Member of Scientific Advisory Board
Feroz Dewan 48 2022 Independent Director
David L. Rimm - 2021 Member of Scientific Advisory Board
Sangeeta N. Bhatia 55 2022 Member of Scientific Advisory Board
Robert M. Hershberg 62 - Member of Scientific Advisory Board
Phillip A. Sharp 79 2021 Member of Scientific Advisory Board
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

DHR Comments

Write your thoughts about Danaher Corporation
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email